RA Capital Management reports USD 412,776 Artiva Biotherapeutics common share purchase

RA Capital Management, a director-level 10% owner of Artiva Biotherapeutics, reported purchasing 41,319 common shares on the open market at $9.99 per share. Following this transaction, their total beneficial ownership stands at 17,283,802 shares.

RA Capital Management, a director-level 10% owner, reported an open-market purchase of 41,319 Artiva Biotherapeutics common shares. * Purchase price reported at USD 9.99 per share. * Beneficial ownership reported at 17,283,802 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000808), on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

ARTV